Cargando…

The Effects of Ecstasy (MDMA) on Brain Serotonin Transporters Are Dependent on Age-of-First Exposure in Recreational Users and Animals

RATIONALE AND OBJECTIVE: Little is known on the effects of ecstasy (MDMA, a potent 5-HT-releaser and neurotoxin) exposure on brain development in teenagers. The objective of this study was to investigate whether in humans, like previous observations made in animals, the effects of MDMA on the 5-HT s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klomp, Anne, den Hollander, Bjørnar, de Bruin, Kora, Booij, Jan, Reneman, Liesbeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480359/ https://www.ncbi.nlm.nih.gov/pubmed/23115651 http://dx.doi.org/10.1371/journal.pone.0047524

Ejemplares similares

Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter
por: Kuypers, K. P. C., et al.
Publicado: (2018)

Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
por: Kamboj, Sunjeev K., et al.
Publicado: (2017)

The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies
por: Vegting, Yosta, et al.
Publicado: (2016)

Malignant hyperpyrexia in an MDMA ("Ecstasy") abuser.
por: McCoy, E. P., et al.
Publicado: (1994)

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
por: Wunderli, Michael D, et al.
Publicado: (2017)

Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation
por: Puerta, Elena, et al.
Publicado: (2011)

Ecstasy (MDMA): A rebellion coherent with the system
por: García-Montes, José Manuel, et al.
Publicado: (2020)

Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA (“Ecstasy”) in Rats and Preserves Affinity for the Serotonin Transporter (SERT)
por: Sáez-Briones, Patricio, et al.
Publicado: (2019)

Induced fit, ensemble binding space docking and Monte Carlo simulations of MDMA ‘ecstasy’ and 3D pharmacophore design of MDMA derivatives on the human serotonin transporter (hSERT)
por: Islas, Ángel A., et al.
Publicado: (2021)

Ecstasy (MDMA) and its effects on kidneys and their treatment: a review
por: Bora, Feyza, et al.
Publicado: (2016)

Caffeine and MDMA (Ecstasy) Exacerbate ER Stress Triggered by Hyperthermia
por: Trychta, Kathleen A., et al.
Publicado: (2022)

Neurotoxicity of drugs of abuse - the case of methylenedioxy amphetamines (MDMA, ecstasy ), and amphetamines
por: Gouzoulis-Mayfrank, Euphrosyne, et al.
Publicado: (2009)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022)

Effects of dexamphetamine-induced dopamine release on resting-state network connectivity in recreational amphetamine users and healthy controls
por: Schrantee, Anouk, et al.
Publicado: (2015)

Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model
por: Jamshidfar, Sanaz, et al.
Publicado: (2017)

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
por: Makunts, Tigran, et al.
Publicado: (2022)

Chronic exposure to MDMA (Ecstasy) elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants
por: Modi, Gunjan M, et al.
Publicado: (2006)

Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice
por: Górska, Anna Maria, et al.
Publicado: (2017)

Fatal and non-fatal health incidents related to recreational ecstasy use
por: van Amsterdam, Jan, et al.
Publicado: (2020)

Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters
por: Hagino, Y, et al.
Publicado: (2011)

Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data
por: Salvatore, Stefania, et al.
Publicado: (2016)

COMTVal158Met polymorphism is associated with ecstasy (MDMA)-induced psychotic symptoms in the Turkish population
por: Aytac, Hasan Mervan, et al.
Publicado: (2022)

Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study
por: Hysek, Cédric M., et al.
Publicado: (2012)

Saturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes
por: Parrott, Andrew C, et al.
Publicado: (2014)

Erratum to: Exploring functional data analysis and wavelet principal component analysis on ecstasy (MDMA) wastewater data
por: Salvatore, Stefania, et al.
Publicado: (2017)

Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents
por: Jones, Grant, et al.
Publicado: (2022)

Verbal Memory Deficits Are Correlated with Prefrontal Hypometabolism in (18)FDG PET of Recreational MDMA Users
por: Bosch, Oliver G., et al.
Publicado: (2013)

Increased Response to a 5-HT Challenge After Discontinuation of Chronic Serotonin Uptake Inhibition in the Adult and Adolescent Rat Brain
por: Klomp, Anne, et al.
Publicado: (2014)

Effects of alcohol (BAC 0.5‰) and ecstasy (MDMA 100 mg) on simulated driving performance and traffic safety
por: Veldstra, Janet L., et al.
Publicado: (2011)

Nephroprotective effects of Feijoa Sellowiana leaves extract on renal injury induced by acute dose of ecstasy (MDMA) in mice
por: Karami, Mohammad, et al.
Publicado: (2014)

Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells
por: Popova, Dina, et al.
Publicado: (2016)

Careers in ecstasy use: do ecstasy users cease of their own accord? Implications for intervention development
por: Peters, Gjalt-Jorn Ygram, et al.
Publicado: (2008)

Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy)
por: Movassaghi, Shabnam, et al.
Publicado: (2013)

Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample
por: Jones, Grant, et al.
Publicado: (2023)

RAVE DRUG (ECSTASY) AND SELECTIVE SEROTONIN REUPTAKE INHIBITOR ANTI-DEPRESSANTS
por: Singh, A.N., et al.
Publicado: (2000)

Disrupted ‘reflection’ impulsivity in cannabis users but not current or former ecstasy users
por: Clark, L, et al.
Publicado: (2009)

Meta-analysis of executive functioning in ecstasy/polydrug users
por: Roberts, C. A., et al.
Publicado: (2016)

MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid
por: Bosker, Wendy M., et al.
Publicado: (2011)

Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study
por: Schrantee, Anouk, et al.
Publicado: (2019)

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
por: Pardo-Lozano, Ricardo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6v1l10i1cf7ie4gpqkedq6ghb4